Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model.
- Published In:
- Neurobiology of disease, 44(3), 327-39 (2011)
- Authors:
- Idan-Feldman, Anat, Schirer, Yulie, Polyzoidou, Eleni, Touloumi, Olga, Lagoudaki, Roza, Grigoriadis, Nikolaos C, Gozes, Illana
- Database ID:
- RPEP-01781
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01781APA
Idan-Feldman, Anat; Schirer, Yulie; Polyzoidou, Eleni; Touloumi, Olga; Lagoudaki, Roza; Grigoriadis, Nikolaos C; Gozes, Illana. (2011). Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model.. Neurobiology of disease, 44(3), 327-39. https://doi.org/10.1016/j.nbd.2011.06.020
MLA
Idan-Feldman, Anat, et al. "Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model.." Neurobiology of disease, 2011. https://doi.org/10.1016/j.nbd.2011.06.020
RethinkPeptides
RethinkPeptides Research Database. "Davunetide (NAP) as a preventative treatment for central ner..." RPEP-01781. Retrieved from https://rethinkpeptides.com/research/idan-feldman-2011-davunetide-nap-as-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.